Searchable abstracts of presentations at key conferences in endocrinology

ea0090p809 | Late-Breaking | ECE2023

Somatostatin Analogues or Active Surveillance in Sporadic and MEN1 associated Non-functioning Pancreatic Neuroendocrine Tumors

Raia Salvatore , Chiloiro Sabrina , Grazia Maratta Maria , Maiorano Brigida , Rossi Ernesto , Gabriella Brizi Maria , Rufini Vittoria , De Marinis Laura , Pontecorvi Alfredo , Tortora Giampaolo , Rindi Guido , Schinzari Giovanni , Bianchi Antonio

Introduction: Non-functioning (NF), sporadic and MEN1 associated, G1-G2 pancreatic neuroendocrine tumors (PanNETs) usually display an indolent course. Surgery is the first-choice treatment for localized tumors >2 cm. Unresectable or metastatic PanNETs expressing somatostatin receptors (SSTRs) are treated with somatostatin analogs (SSAs). The standard treatment for patients with PanNETs ≤ 2 cm is active surveillance (AS). Yet no evidence of the value of SSA treatment ...

ea0063p681 | Pituitary and Neuroendocrinology 2 | ECE2019

First case of mature teratoma and yolk sac testis tumor associated to inherited MEN-1 syndrome: a case report

Chiloiro Sabrina , Domenico Capolungo Ettore , Schinzari Giovanni , Concolino Paola , Rossi Ernesto , Martini Maurizio , Cocomazzi Alessandra , Grande Giuseppe , Milardi Domenico , Maiorano Brigida , Giampietro Antonella , Rindi Guido , Pontecorvi Alfredo , De Marinis Laura , Bianchi Antonio

Introduction: Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominantly inherited endocrine tumor syndrome characterized by development of cancer in various endocrine organs, particularly in pituitary, parathyroid and pancreas. Moreover, in some cases, also non-endocrine tumors can be diagnosed, developing atypical phenotypes.Case report: We report herein the clinical history of a patient affected by MEN-1 syndrome who developed atypical feat...